However, it is interesting to underline that PI3K and NF-kB pathways are both involved in curcumin anti-tumour activity [50] and inhibition of NF-kB activation may account for curcumin efficacy on cancer cells [18] and, specifically, on human melanoma cells [19,20]. This evidence concerns the gene NFKB1 and melanoma.